D-1467-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1467-2019 was initiated by American Health Packaging on May 9, 2019 and is designated Class II. Reason for recall: GMP Deviations: Potential cross contamination due to cleaning procedure failure. The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 375,921 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 17, 2019
Initiation Date
May 9, 2019
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
375,921 bottles

Product description

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

Reason for recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Distribution pattern

Nationwide USA

Code information

Count, Lot, Expiry: [30-count bottle] Lots M711214, M711215, M711216, M711217, exp 8/31/2019; Lots M802198, M802199, exp 1/31/2020; Lots M805203, M805204, M805207, exp 3/31/2019; Lots M812455, exp 6/30/2020; Lot M815766, exp 9/30/2020; Lots M818633, M818634, exp 10/31/2020; Lots M819858, M819859, exp 11/30/2020 [1000-count bottle] Lot M711218, exp 8/31/2019; Lot M802197, exp 1/31/2020; Lots M805209, M805946, exp 3/31/2020; Lot M812456, exp 6/30/2020; Lots M815767, M818273, exp 9/30/2020; Lot M819857, exp 11/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1467-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1467-2019. Report a data issue: hello@regdatalab.com.